Search

everythinglearnresearchcommunity

for

Search:↓

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

Gray hair can potentially be reversed, leading to new treatments.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

A woman had a rare skin condition with recurring painful nodules that heal in 6 weeks, often without needing treatment.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

The review concluded that keeping the hair-growing ability of human dermal papilla cells is key for hair development and growth.

New cancer treatments aim to reduce side effects and improve effectiveness.

Too much epidermal growth factor can cause hair loss.

Exosomes could improve skin care, but more research is needed to confirm their safety and effectiveness.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

Most patients improved with oral antibiotics, but some needed long-term treatment or had minimal response.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Transethosomes improve drug delivery through the skin and show promise for treating various conditions.

Latanoprost-loaded nanotransfersomes could help treat hair loss by promoting hair growth.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

New therapies are being developed that target integrin pathways to treat various diseases.

A protein called desmoglein 3 is important for keeping hair follicle stem cells inactive and helps in their regeneration.

Activating Nrf2 in skin cells speeds up wound healing by increasing the growth of certain stem cells.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.